As a partner in our Intellectual Property Group in London, I have extensive experience in patent litigation in the life sciences - pharma and biotech - and also in non-contentious work on the exploitation of IP rights.

I often provide advice on IP disputes with an international element, frequently co-ordinating with US clients and advisors, as well as running pan-European patent actions across a number of jurisdictions. My role also involves providing commercial advice on the development, protection and exploitation of IP.

I often speak about IP issues to an international audience, including at the Technology Transfer Summit and Life Sciences IP Minds Conference. In 2017, I taught IP at The Oxford Said Business School, an IP summer school at Cambridge University and a Post Graduate IP Diploma at Oxford University.

I have a first class degree in Chemistry from Oxford and was recognised as a 'next generation' lawyer in Pharma and Biotech by the Legal 500. I am a member of the European Patent Lawyers Association and American Intellectual Property Lawyers Association.

  • Allergan (Ganfort/timolol and bimatoprost) v Aspire
  • Takeda (glycosylation of antibodies) v Roche
  • Allergan (Lumigan/bimatoprost) v Aspire and Accord
  • Husqvarna (robotic lawnmowers) v Positec
  • Actavis (telmisartan and hydrochlorothiazide SPC) v Boehringer Ingelheim
  • Allergan (Botox second medical use) v Ipsen
  • University of Oxford, Postgraduate Diploma in Intellectual Property Law & Practice
  • BPP Law School, LPC
  • BPP Law School, Postgraduate Diploma in Law
  • University of Oxford, MChem, Chemistry
  • Law Society of England & Wales in 2006